This heterogeneity manifested through inflammatory cytokine stimulation, such as IL-1B, and the upregulation of the ELF3 gene, which activated the PI3K/Akt/NF-κB pathway, thereby enhancing the expression of tumor genes linked to proliferation and anti-apoptosis mechanisms [37]. The gene discussed is NFKB1; the disease is neoplasm.